SCHOTT Group Wins Gold Stevie Awards for Technology Excellence with SCHOTT TOPPAC® Nest 160 and Lightweight Microelectronic Packages
August 07 2024 - 1:46PM
Business Wire
- SCHOTT TOPPAC® Nest 160 revolutionizes drug containment
solutions, offering increased capacity and improved efficiency by
up to 67% in the fill-and-finish process of prefillable polymer
syringes.
- Lightweight microelectronic packages provide robust protection
for aerospace electronics while weighing up to two-thirds less than
conventional solutions.
- Both innovations address critical industry needs: high-speed,
large-scale production in pharmaceuticals and fuel efficiency
without compromising protection in aerospace.
SCHOTT, the international technology group and inventor of
specialty glass, has been honored with two Gold Stevie Awards for
Technology Excellence, recognizing its groundbreaking innovations
in microelectronics as well as SCHOTT Pharma’s newest drug
containment solution.
The awards celebrate two of the Group’s cutting-edge products:
SCHOTT Pharma’s SCHOTT TOPPAC® Nest 160, a revolutionary solution
that improves the fill-and-finish process of prefillable polymer
syringes, and SCHOTT’s lightweight microelectronic packages,
innovative aluminum-based packages designed for aircraft and
satellite applications.
The Stevie Awards for Technology Excellence celebrate the
remarkable accomplishments of individuals, teams, and organizations
shaping the future of technology across all industry sectors.
Winners of the awards, named the Stevies from the Greek word
meaning “crowned,” will be recognized during a gala awards dinner
on Monday, Sept. 16, 2024, at the Marriott Marquis Hotel in New
York City.
“These prestigious awards validate our commitment to pushing the
boundaries of technology and delivering innovative solutions that
address critical industry needs,” said Dr. Frank Heinricht, CEO of
SCHOTT. “Our lightweight microelectronic packages exemplify our
dedication to driving progress in the aerospace sector. While we’ve
always been pioneers in specialty glass technology, we’re applying
that same ingenuity to a broader range of materials and challenges
across all the verticals we serve,” he added. Andreas Reisse, CEO
of SCHOTT Pharma adds: “We’re excited that our new nest for
prefillable polymer syringes is being recognized for its innovative
power. With it, we’re actively addressing one of the main levers to
improve the costs of pharma companies and reorganizing their value
chain.”
Launched in July 2024, SCHOTT Pharma's SCHOTT TOPPAC® Nest 160
has been recognized for its transformative impact on the
fill-and-finish process of prefillable polymer syringes. This
innovative solution meets the continuous need to improve the
productivity of high-speed, large-scale production without
compromising compliance or quality. The SCHOTT TOPPAC® Nest 160
offers a significant 60% increase in filling capacity compared to
previous nests, accommodating almost two-thirds more polymer
syringes in one nest at lower costs. This advancement allows
pharmaceutical companies to fill significantly more syringes per
hour than with the standard nest. By leveraging economies of scale,
the product offers an increase in efficiency by up to 67%, a
significant reduction of manufacturing costs, and a reduction of
the product carbon footprint by 17%.
SCHOTT's lightweight microelectronic packages, introduced in
November 2023, have earned acclaim for an innovative approach to
protecting sensitive electronics in aerospace applications. These
aluminum-based packages offer robust protection against harsh
conditions while weighing up to two-thirds less than conventional
Kovar packaging. Suitable for microwave/RF packages, DC/DC
converter packages, and hermetic sensor packages, these innovative
solutions are designed specifically for aircraft and satellite
applications. Fully customizable to meet unique and challenging
requirements, SCHOTT’s lightweight microelectronic packages
maintain high-level protection against extreme pressure, vibration,
and temperature conditions. This innovation addresses a critical
need in the aviation and space manufacturing sectors, allowing
manufacturers to enhance fuel efficiency without compromising on
long-term, reliable protection for sensitive electronics.
Learn more about SCHOTT’s lightweight microelectronic packages
and SCHOTT Pharma’s SCHOTT TOPPAC® Nest 160.
About SCHOTT
International technology group SCHOTT produces high-quality
components and advanced materials, including specialty glass,
glass-ceramics, and polymers. Many SCHOTT products have high-tech
applications that push technological boundaries, such as flexible
glass in foldable smartphones, glass-ceramic mirror substrates in
the world's largest telescopes, and laser glass in nuclear fusion.
With their pioneering spirit, SCHOTT’s 17,100 employees in over 30
countries work as partners to industries such as healthcare, home
appliances, consumer electronics, semiconductors, optics,
astronomy, energy, and aerospace. In fiscal year 2023, SCHOTT
generated 2.9 billion euros in sales. In addition to innovation,
one of its important corporate goals is sustainability, where it is
pursuing climate neutral production by 2030. SCHOTT was founded in
1884 and is headquartered in Mainz, Germany. The company belongs to
the Carl Zeiss Foundation, which uses its dividends to promote
science. Further information at SCHOTT.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240807460109/en/
Press: Rina Della Vecchia rina.dellavecchia@us.schott.com
Lexie Capperella lexie@gregoryfca.com